Articles

1. Pushing Poorly Soluble APIs Into Development 11/6/2013

   The active pharmaceutical ingredients (APIs) screened and selected to be transformed into efficacious and safe medicines often require alternative, innovative strategies in order to facilitate this journey and enable new therapies to enter the market.

2. DSM's Route Scouting & Implementation of Synthetic Processes Is A Cost-effective Solution For Commercialization 3/28/2012
   DSM's cost-effective solution in route design and implementation of synthetic processes offers the capability to support emerging pharma companies with high potential and biotechs project and small molecule projects.
3. Brochure: RHOBUST® Downstream Processing Technology 2/22/2012
   Rhobust® technology is a downstream processing technology for the manufacturing of recombinant proteins and antibodies.
4. Brochure: XD® Technology: Improve Biopharmaceutical Production 2/22/2012
   DSM's XD® Technology has been developed to drive yield improvements in the production of biopharmaceuticals.
5. Brochure: Biologics Contract Manufacturing & Technology Solutions 1/30/2012

   DSM provides turn-key biologic manufacturing solutions, contract manufacturing for preclinical development, clinical trials or commercial supply and reduced cost, risk, and time to market.

6. Accelerating Generic Approvals: 5 Keys To Being First To Market 12/12/2011

   Competition in the generics market has never been greater. At a time when many of the most successful drugs are reaching the patent cliff, opening the floodgates for generic substitutes, generic companies are rushing to target the best candidates and enter the market first.

7. Five Year Trouble Free Manufacturing For Large Pharma Company 9/28/2011

   Alkermes, through the merger with Elan Drug Technologies, to become Alkermes plc, has been developing and manufacturing commercial scale solid oral dosage products for over 40 years.

8. Alkermes Contract Pharma Services 9/28/2011

   With Alkermes Contract Pharma Services, you have the opportunity to outsource your development, scale-up and manufacturing requirements to a trusted, experienced and dedicated expert in outsourcing services.

9. Sharpening Your Competitive Edge And Driving Cost Savings Through Strategic Outsourcing 8/25/2011

   During uncertain times, outsourcing laboratory services can make sense — especially as a critical component to a company’s bottom line. Today, more and more life sciences companies are looking at outsourcing laboratory services as a business strategy to drive cost savings and realizing that an array of services can be outsourced in the pharmaceutical and biopharmaceutical industries. By Tina Sturgill, senior director of biological sciences and director of site operations, Celsis Analytical Services

10. White Paper: Understanding the 505(b)(2) Approval Pathway 8/5/2011

    Explore how the 505(b)(2) regulatory pathway can help drug developers gain approval for new drugs in a fraction of the time and cost required by traditional paths.